InMed Pharmaceuticals Inc. (INM) has 18 known insider and institutional holders on record. The largest holder is MANCINI ALEXANDRA DIANE JANET with 52,485 shares. Other notable holders include ADAMS ERIC A and Tegge Jonathan.
Over the last 12 months, insiders have made 16 transactions in INM stock — 10 buys (valued at $135.71K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
INM Insider Ownership
Top Holder
MANCINI ALEXANDRA DIANE JANET
52,485 shares
Buys (12 mo)
10
$135.71K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Mancini Alexandra Diane Janet |
Sr VP, Clinical Reg Affairs |
52,485 |
2024-03-05 |
|
| 2 |
Adams Eric A |
President & CEO |
49,050 |
2025-12-19 |
|
| 3 |
Tegge Jonathan |
Interim CFO |
31,400 |
2023-12-26 |
|
| 4 |
Sazdanoff Catherine |
Director |
29,091 |
2021-12-30 |
|
| 5 |
Woudenberg Michael |
Chief Operating Officer |
25,445 |
2025-12-19 |
|
| 6 |
Jagpal Netta |
Chief Financial Officer |
24,250 |
2025-12-19 |
|
| 7 |
Hsu Eric C |
Sr. VP, Pre-clinical Res/dev |
18,280 |
2025-12-19 |
|
| 8 |
Garner William J |
Director |
16,122 |
2022-01-24 |
|
| 9 |
Cutler Adam D. |
Director |
16,122 |
2022-01-24 |
|
| 10 |
Johnson Shane Aaron |
Sr VP & General Manager |
12,400 |
2025-12-19 |
|
| 11 |
Colwill Bruce |
CFO |
11,515 |
2022-01-24 |
|
| 12 |
Klompas Neil A |
Director |
5,250 |
2025-12-19 |
|
| 13 |
Bathery John Steven |
Director |
5,250 |
2025-12-19 |
|
| 14 |
Li Sarah |
VP Accounting & Controller |
4,002 |
2022-12-19 |
|
| 15 |
Lemerond Nicole |
Director |
2,725 |
2025-12-19 |
|
| 16 |
Hull Andrew |
Director |
2,711 |
2025-12-19 |
|
| 17 |
Baldasare Bryan T |
Director |
975 |
2024-12-23 |
|
| 18 |
Grove Janet P |
Director |
975 |
2024-12-23 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2025-12-19 |
Bathery John Steven |
Director |
RSU Award |
1,750 |
$1.29 |
$2.26K |
| 2025-12-19 |
Jagpal Netta |
Chief Financial Officer |
RSU Award |
18,000 |
$1.29 |
$23.22K |
| 2025-12-19 |
Lemerond Nicole |
Director |
RSU Award |
1,750 |
$1.29 |
$2.26K |
| 2025-12-19 |
Johnson Shane Aaron |
Sr VP & General Manager |
RSU Award |
8,500 |
$1.29 |
$10.97K |
| 2025-12-19 |
Hull Andrew |
Director |
RSU Award |
1,750 |
$1.29 |
$2.26K |
| 2025-12-19 |
Woudenberg Michael |
Chief Operating Officer |
RSU Award |
18,000 |
$1.29 |
$23.22K |
| 2025-12-19 |
Adams Eric A |
President & CEO |
RSU Award |
35,000 |
$1.29 |
$45.15K |
| 2025-12-19 |
Hsu Eric C |
Sr. VP, Pre-clinical Res/dev |
RSU Award |
13,000 |
$1.29 |
$16.77K |
| 2025-12-19 |
Klompas Neil A |
Director |
RSU Award |
1,750 |
$1.29 |
$2.26K |
| 2025-12-15 |
Hull Andrew |
Director |
Option Expired |
14 |
$1,397.97 |
$19.57K |
| 2025-12-15 |
Woudenberg Michael |
Chief Operating Officer |
Option Expired |
60 |
$1,397.97 |
$83.88K |
| 2025-12-15 |
Adams Eric A |
President & CEO |
Option Expired |
250 |
$1,397.97 |
$349.49K |
| 2025-12-15 |
Hsu Eric C |
Sr. VP, Pre-clinical Res/dev |
Option Expired |
70 |
$1,397.97 |
$97.86K |
| 2025-10-14 |
Bathery John Steven |
Director |
Unknown |
3,500 |
$2.10 |
$7.35K |
| 2025-10-17 |
Klompas Neil A |
Director |
RSU Award |
3,500 |
$2.10 |
$7.35K |
| 2024-10-09 |
Klompas Neil A |
Director |
Unknown |
- |
- |
- |
